Announced Mon, 8 Jun · 19:57 IST

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.1%1-day move
₹2255.95
prior close
₹2301.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.1-0.1+0.5+3.1-0.3+2.0+3.4+13.0+15.7+24.1+16.8
Up moveDown movePending
AI summary

Fredun Pharmaceuticals has informed BSE that it is sending letters to shareholders whose email addresses are not registered with the company, its RTA (Purva Sharegistry), or depository participants. These letters provide the weblink to access the Annual Report for FY 2025-26 and the Notice of the 39th Annual General Meeting. The AGM is scheduled for Tuesday, June 30, 2026, at 9:00 am via Video Conferencing/Other Audio Visual Means. The cut-off date for identifying shareholders without registered emails was May 29, 2026. The letter also reminds physical security holders to update their KYC details (PAN, address, mobile, bank details, specimen signature, and nomination) as mandated by SEBI, with payments to non-compliant folios to be made only via electronic mode from April 1, 2024.

Likely market impact

This is a routine procedural compliance filing with no material impact on shareholders or the stock price. Shareholders holding shares in physical form or without registered emails should take note of the AGM date and update their KYC to avoid disruptions in receiving dividends or other communications.